S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
What to watch for as China's major political meeting of the year gets underway
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
What to watch for as China's major political meeting of the year gets underway
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
What to watch for as China's major political meeting of the year gets underway
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
What to watch for as China's major political meeting of the year gets underway
OTCMKTS:IOBCF

Ion Beam Applications (IOBCF) Stock Price, News & Analysis

$10.35
0.00 (0.00%)
(As of 03/1/2024 ET)
Today's Range
$10.35
$10.35
50-Day Range
$10.35
$12.46
52-Week Range
$8.65
$19.55
Volume
N/A
Average Volume
511 shs
Market Capitalization
N/A
P/E Ratio
122.10
Dividend Yield
N/A
Price Target
N/A

IOBCF stock logo

About Ion Beam Applications Stock (OTCMKTS:IOBCF)

Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN (Belgian nuclear research center) to enable the production of Actinimum-225 (225Ac), a novel radioisotope for the treatment of cancer; and an agreement with University of Pennsylvania for research in ConformalFLASH. It also has a research partnership with Particle Therapy Interuniversity Center Leuven for the development of ConformalFLASH1. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.

IOBCF Stock Price History

IOBCF Stock News Headlines

Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
IBA Notice of Full Year 2023 Results and Conference Call
IBA – TRANSPARENCY NOTIFICATION
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Ion Beam Applications SA (IBAB.BR)
Ion Beam Applications SA
IBA SA: IBA Business Update - Third Quarter 2023
IBA Business Update – Third Quarter 2023
IBA SA: IBA Reports Half Year 2023 Results
IBA Reports Half Year 2023 Results
See More Headlines
Receive IOBCF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ion Beam Applications and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
OTCMKTS:IOBCF
CIK
N/A
Fax
N/A
Employees
2,000
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Pierre Mottet (Age 62)
    Chairman of The Board
    Comp: $56.48k
  • Mr. Olivier Legrain (Age 56)
    CEO, President, MD & Executive Director
    Comp: $946.8k
  • Mr. Yves Jongen (Age 77)
    Founder, Chief Research Officer, MD & Executive Director
    Comp: $620.71k
  • Ms. Soumya Chandramouli (Age 45)
    Chief Financial Officer
  • Mr. Frederic Nolf (Age 51)
    Chief Human Resources & Sustainability Officer
  • Marc Van der Burght
    Chief Operation Officer
  • Olivier Lechien
    Corporate Communication Director
  • Thomas Canon
    Sustainability Program Director
  • Bruno Scutnaire
    President of IBA RadioPharma Solutions














IOBCF Stock Analysis - Frequently Asked Questions

How have IOBCF shares performed in 2024?

Ion Beam Applications' stock was trading at $12.46 on January 1st, 2024. Since then, IOBCF shares have decreased by 16.9% and is now trading at $10.35.
View the best growth stocks for 2024 here
.

How do I buy shares of Ion Beam Applications?

Shares of IOBCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:IOBCF) was last updated on 3/3/2024 by MarketBeat.com Staff